Associated Papers
Familial nonmedullary thyroid cancer: a case series in Iranian patients with a meta-review of case series.
Mohammadi Zaniani Z et al.
Laboratory Medicine, 2024
Genetic susceptibility to hereditary non-medullary thyroid cancer.
Kamani T et al.
Hereditary Cancer in Clinical Practice, 2022
Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).
Diquigiovanni C et al.
Cancers, 2021
Familial non medullary thyroid carcinoma: Beyond the syndromic forms.
Orois A et al.
Endocrinologia, Diabetes Y Nutricion, 2021
Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.
Cameselle-Teijeiro JM et al.
Endocrine Pathology, 2021
Workflow for the Implementation of Precision Genomics in Healthcare.
Mehandziska S et al.
Frontiers in Genetics, 2020
32695137 (PubMed )
Supplement: Data_Sheet_2.XLSX › Actionable_conditions
HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
Pinheiro M et al.
Oncotarget, 2017
Familial non-medullary thyroid cancer: unraveling the genetic maze.
Peiling Yang S et al.
Endocrine-related Cancer, 2016
HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
Weeks AL et al.
Bmc Medical Genetics, 2016
Genetic predisposition for nonmedullary thyroid cancer.
Nagy R et al.
Hormones & Cancer, 2015
SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.
He H et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
Select a paper to view details